1. Date of board resolution: 2026/04/29 2. Date of shareholders' meeting: 2026/06/12 3. Location of shareholders' meeting: 3F, No. 9, Section 1, Nanjing East Road, Taipei City (Okura Prestige Taipei, Jiuhua Hall 2) 4. Method of shareholders' meeting (physical/video-assisted/video): Physical shareholders' meeting 5. Agenda Item 1: Reporting matters (1): 2025 Business Report (2): 2025 Audit Committee Review Report (3): Report on the distribution of shareholder cash dividends and stock bonuses for 2025 (4): Amount of directors' remuneration and employees' remuneration for 2025 (5): Adjustment of the company's distributable earnings due to the adoption of International Financial Reporting Standards and the amount of special retained earnings reversed (6): Revision of the "Rules of Procedure for Board Meetings" (7): Report on the phased divestment of shares in connection with the application of the company's subsidiary, "San Fu Biotech Co., Ltd.," for stock listing. 6. Agenda Item 2: Approval matters (1): Approval of 2025 Business Report and Financial Statements (2): 2025 Profit Distribution Proposal 7. Agenda Item 3: Discussion matters (1): Proposal for distributing cash dividends from capital surplus (2): Revision of the "Rules of Procedure for Shareholders' Meetings" 8. Ad hoc motions: 9. Start date of book closure: 2026/04/14 10. End date of book closure: 2026/06/12 11. Other matters to be specified: None.
FACT BOX
- Source: PR Times
- Category: Event